With the integration of frog and Cambridge Consultants, Capgemini Invent now comprises a global team of 10,000 strategists, data scientists, product and experience designers, brand experts and technologists.

Helius Medical Technologies’ groundbreaking PoNS device for short-term treatment of gait deficit due to multiple sclerosis has received marketing authorization from the U.S. Food and Drug Administration (FDA). 

Cambridge Consultants developed the ground-breaking optics technology powering Ellume’s FDA authorized COVID-19 Home Test